Eventide Asset Management - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 319 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.64 and the average weighting 0.2%.

Quarter-by-quarter ownership
Eventide Asset Management ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$11,783,667
-41.4%
372,665
-24.4%
0.21%
-37.6%
Q2 2023$20,113,593
+9.4%
493,2220.0%0.34%
+0.9%
Q1 2023$18,382,384
+65.2%
493,222
+54.6%
0.34%
+53.9%
Q4 2022$11,129,910
-37.7%
319,0000.0%0.22%
-37.6%
Q3 2022$17,851,000
-41.1%
319,000
-42.1%
0.35%
-24.5%
Q4 2020$30,327,000551,4000.46%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Discovery Value Fund 561,561$17,756,5599.73%
MPM BioImpact LLC 544,639$17,221,4854.60%
Casdin Capital, LLC 1,178,075$37,250,7324.12%
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 1,145,091$36,207,7773.72%
Atlas Venture Associates IX, LLC 10,000$316,2002.69%
Deep Track Capital, LP 2,000,000$63,240,0002.44%
ARK Investment Management 9,948,629$314,575,6382.41%
Merlin Capital, Inc 18,526$585,7922.19%
Orchard Capital Management, LLC 159,155$5,032,4811.86%
TANG CAPITAL MANAGEMENT LLC 397,600$12,572,1121.77%
View complete list of INTELLIA THERAPEUTICS INC shareholders